secwatch / observer
8-K filed November 2, 2023, 7:59 PM ET ticker MD CIK 0000893949
earnings confidence high sentiment negative materiality 0.75

Pediatrix Q3 GAAP EPS $0.26, Adjusted EPS $0.32; FY guidance $200-210M

Pediatrix Medical Group, Inc.

2023-Q3 EPS reported $0.77 revenue$1,498,197,000

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

Pediatrix Medical Group, Inc. reported financial results for three months ended September 30, 2023.

Period
three months ended September 30, 2023
Result
reported results
Exact text from the filing
On November 2, 2023, Pediatrix Medical Group, Inc., a Florida corporation (the “Company”), issued a press release announcing the results of its operations for the three months and nine months ended September 30, 2023 (the “Third Quarter Release”). A copy of the Third Quarter Release is attached hereto as Exhibit 99.1 and is hereby incorporated in this Current Report by reference.
View on SEC.gov
Earnings Releases SEC 8-K Item 2.02 confidence 0.95

Pediatrix Medical Group, Inc. reported financial results for nine months ended September 30, 2023.

Period
nine months ended September 30, 2023
Result
reported results
Exact text from the filing
On November 2, 2023, Pediatrix Medical Group, Inc., a Florida corporation (the “Company”), issued a press release announcing the results of its operations for the three months and nine months ended September 30, 2023 (the “Third Quarter Release”). A copy of the Third Quarter Release is attached hereto as Exhibit 99.1 and is hereby incorporated in this Current Report by reference.
View on SEC.gov

Browse all earnings releases →

Pediatrix Medical Group, Inc. filing history →

Source: SEC EDGAR
accession 0000950170-23-057732
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.